Management of gastrointestinal bleeding in cirrhotic patients.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D017679:Cryotherapy; D004322:Drainage; D004939:Esophageal Perforation / Q000209:etiology; D004932:Esophageal and Gastric Varices / Q000628:therapy; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D006487:Hemostasis; D006501:Hepatic Encephalopathy / Q000517:prevention & control; D006801:Humans; D006975:Hypertension, Portal / Q000628:therapy; D007441:Intubation, Gastrointestinal / Q000009:adverse effects; D008103:Liver Cirrhosis / Q000150:complications*; D009203:Myocardial Infarction / Q000139:chemically induced; D010437:Peptic Ulcer / Q000150:complications; D011015:Pneumonia, Aspiration / Q000209:etiology; D011167:Portacaval Shunt, Surgical; D012597:Sclerosing Solutions / Q000008:administration & dosage; D007507:Therapeutic Irrigation; D014456:Ulcer / Q000209:etiology; D014667:Vasopressins / Q000009:adverse effects / Q000627:therapeutic use; D014812:Vitamin K / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D012597:Sclerosing Solutions; D014667:Vasopressins; D014812:Vitamin K